A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, parallel group study to assess the hemodynamic effect of
three different dose regimens of a sustained release (SR) tablet of UT-15C in patients with
exercise-induced pulmonary hypertension (PH), as measured by the change in peak total
pulmonary resistance index (TPRI) during exercise from Baseline to Week 12.